CHARACTERIZATION OF THE TUMOR CELL LAMELLIPODIA PHOSPHOPROTEOME

肿瘤细胞板状伪足磷酸蛋白质组的表征

• 批准号: 7721390
• 负责人: Richard L. Klemke
• 金额: $ 7.2万
• 依托单位: BATTELLE PACIFIC NORTHWEST LABORATORIES
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-08 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7721390
• 关键词: Adenocarcinoma Cell; Animal Model; Antibodies; Biochemical; Bioinformatics; Biological Assay; Breast Adenocarcinoma; CCL26 gene; Cells; Complex; Computer Retrieval of Information on Scientific Projects Database; Computer Simulation; Epithelial; Funding; Goals; Grant; Human; Institution; Kidney; Laboratories; Location; Mediating; Methods; Molecular; Monkeys; National Center for Research Resources; Neoplasm Metastasis; Patients; Phosphopeptides; Phosphotyrosine; Process; Proteins; Recurrent disease; Research; Research Personnel; Resolution; Resources; Signal Transduction; Site-Directed Mutagenesis; Small Interfering RNA; Source; Testing; Therapeutic Intervention; Tyrosine; Tyrosine Phosphorylation; United States National Institutes of Health; base; cancer cell; cell motility; genetic regulatory protein; imidazole-4-acetic acid; neoplastic cell; new technology; research study; tumor progression

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of my laboratory is to understand the molecular signaling mechanisms that control tumor cell migration, invasion, and metastasis. Metastasis is a major cause of disease relapse and decreased patient survival. Recently, we developed a biochemical method to purify the leading front (lamellipodia) of migrating cells (JCB 156:725. 2002). This novel technology will allow us to identify the key regulatory proteins that facilitate lamellipodia formation, which is responsible for mediating cell invasion and metastasis. We will use monkey kidney epithelial (COS-7) and metastatic human breast adenocarcinoma cells for these studies. Initial analysis has revealed that phosphotyrosine (PY) proteins are highly activated in the lamellipodia of these cells. Pharmacological inhibition of tyrosine phosphorylation inhibits lamellipodia formation, indicating that complex signaling cascades control this process through modulation of tyrosine networks. Therefore, our objective is to characterize the PY proteins (lamellipodia phosphoproteome) responsible for lamellipodia formation and cancer cell metastasis. Lamellipodia PY proteins will be immunopurified with anti-PY antibodies or enriched for phosphopeptides using an IMAC column and then analyzed using the NCRR high sensitivity, high resolution LC-MS/MS to identify key proteins and determine the specific locations of the phosphorylated residues. Functional testing will then be performed using siRNA protein knockdown and site directed mutagenesis followed by cell-based assays and animal models of cell migration established in our laboratory. Information gained from these experiments will then be analyzed using bioinformatics and computer modeling to reveal potential phosphotyrosine networks that contribute to cancer cell metastasis. Results from our study will provide valuable information on the signals that control cell migration and metastasis and provide targets for therapeutic intervention of cancer progression.

这个子项目是众多研究子项目之一